Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

LENZ Therapeutics

LENZNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$23.82

1.325.87%

At close: -

$23.82

0.000.00%

After Hours: 4:00 PM EDT

LENZ Therapeutics (LENZ) Forecast

News

Earnings LENZ Therapeutics (LENZ) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for LENZ Therapeutics (NASDAQ:LENZ) Stock

LENZ Therapeutics Stock (NASDAQ: LENZ)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, November 07, 2024

HC Wainwright & Co. Reiterates Buy on LENZ Th...
Benzinga Newsdesk

Wednesday, November 06, 2024

LENZ Therapeutics Q3 2024 GAAP EPS $(0.38) Be...
Benzinga Newsdesk

Monday, October 28, 2024

LENZ Therapeutics' Investigational Drug For Age-Related Blindness Aces Pivotal China Trial, Analyst Says Data Readout May Strengthen Position For Ex-U.S. Partnerships
Vandana Singh
LENZ Therapeutics shares are trading higher a...
Benzinga Newsdesk
Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Reported Earlier, CORXEL And LENZ Therapeutic...
Benzinga Newsdesk

Monday, October 21, 2024

Why LENZ Therapeutics Stock Hit A New 52-Week High Today
Henry Khederian
LENZ Therapeutics shares are trading higher a...
Benzinga Newsdesk
LENZ Therapeutics Announces FDA Acceptance Of...
Benzinga Newsdesk

Friday, September 27, 2024

LENZ Therapeutics shares are trading higher a...
Benzinga Newsdesk
Raymond James Initiates Coverage On LENZ Ther...
Benzinga Newsdesk

Thursday, August 15, 2024

Piper Sandler Maintains Overweight on LENZ Th...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on LENZ Th...
Benzinga Newsdesk

Wednesday, August 14, 2024

LENZ Therapeutics Q2 EPS $(0.40) Up From $(7....
Benzinga Newsdesk

Monday, August 12, 2024

LENZ Therapeutics Submits New Drug Applicatio...
Benzinga Newsdesk
HC Wainwright & Co. Initiates Coverage On LEN...
Benzinga Newsdesk

Monday, July 15, 2024

LENZ Therapeutics Enters Into $30M Stock Purc...
Benzinga Newsdesk

Monday, June 10, 2024

Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
ICC Holdings, Diamond Offshore Drilling, CrowdStrike And Other Big Stocks Moving Higher On Monday
Avi Kapoor

Wednesday, May 08, 2024

LENZ Therapeutics Q1 2024 GAAP EPS $(3.53) Mi...
Benzinga Newsdesk

Monday, April 15, 2024

Leerink Partners Initiates Coverage On LENZ T...
Benzinga Newsdesk
William Blair Initiates Coverage On LENZ Ther...
Benzinga Newsdesk

Wednesday, April 10, 2024

Blindness-Focused LENZ Therapeutics' Investigational Eye Drop Ready To Revolutionize Presbyopia Landscape, Analyst Says
Vandana Singh
Citigroup Initiates Coverage On LENZ Therapeu...
Benzinga Newsdesk

Wednesday, April 03, 2024

Newly Listed Lenz Therapeutics' Vision Loss Experimental Drug Meets Primary Goal In Late-Stage Study
Vandana Singh
Lenz Therapeutics shares are trading higher a...
Benzinga Newsdesk
Lenz Therapeutics Announced Topline Results F...
Benzinga Newsdesk

Tuesday, April 02, 2024

LENZ Therapeutics To Host Investor Call To Di...
Benzinga Newsdesk

Friday, March 29, 2024

12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights

Wednesday, March 27, 2024

LENZ Therapeutics shares are trading higher a...
Benzinga Newsdesk
Piper Sandler Initiates Coverage On LENZ Ther...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved